Latest Operational Cash Flow News

Aurelia Metals delivers a robust December 2024 quarter, hitting key production targets and marking a milestone with first concentrate from its Federation ore. The company maintains a strong balance sheet while advancing growth projects.

Aurelia Metals delivered a robust December quarter, marked by strong cash flow, increased metal output, and the successful processing of its first ore from the Federation mine, underpinning its FY25 guidance.

Mitchell Services reported a $46.7 million revenue and $5.6 million EBITDA in Q2 FY25, reflecting a strategic transition phase marked by increased mobilisation for new projects in PNG and decarbonisation drilling. Despite short-term softness, the company’s strengthened balance sheet and expanded service offerings position it for growth.

Horizon Minerals reported a $5.165 million cash outflow for Q4 2024 but bolstered its liquidity with a capital raising in January 2025, extending its runway amid ongoing exploration investments.

29Metals Limited delivered a robust December Quarter 2024 update, marked by significant operational progress including high-grade copper discoveries at Europa and a successful debt refinancing that strengthens its financial footing.

Hiremii Limited reports a modest 0.4% revenue increase to $7.5 million in Q2 FY25, underpinned by strategic AI platform deployment and expanding Energy Transition sector opportunities.

Gold Road Resources delivered record gold production and sales in the December 2024 quarter, alongside robust cash flow growth and promising exploration advances, positioning the company for an ambitious 2025.

MEC Resources has successfully completed a $2.65 million entitlement offer and resumed trading on the ASX after nearly five years of suspension. The company is now focused on advancing its energy investments, including navigating ongoing legal issues with its Advent Energy joint venture.

PARKD Ltd reports substantial structural completions on flagship projects and positive operating cash flow in Q2 FY25, setting the stage for licensing negotiations with Fielders.

Bioxyne Limited reports a remarkable 77% revenue increase in Q2 FY2025 alongside positive operating cash flow, setting the stage for international growth with imminent UK export approvals and planned European manufacturing.

Resonance Health has reported record quarterly customer receipts of $5 million, a 57% increase from the previous quarter, alongside a major $13.8 million clinical trial contract win, signaling robust growth across its healthcare technology and clinical trial services.

Bowen Coking Coal reported a strong December quarter with record coal sales and a 39% reduction in cash costs, underpinning a $29 million EBITDA despite softer coal prices.